Research programme: cancer vaccines - Maxygen
Alternative Names: Cancer vaccines research programme - Maxygen; Maxy 1200Latest Information Update: 07 Jun 2013
At a glance
- Originator Maxygen
- Class Cancer vaccines; DNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Colorectal cancer
Most Recent Events
- 07 Jun 2013 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 07 Jun 2013 Discontinued - Preclinical for Colorectal cancer in USA (unspecified route)
- 06 Jun 2006 No development reported - Preclinical for Cancer in USA (unspecified route)